Back
Atara Biotherapeutics, Inc. Stock Predictions
Coinbase Lost $400M. Your Crypto Isn't Safe on Exchanges.
Stop trusting exchanges. Learn how to access Native Markets where YOU control your assets
Sell
23
ATRA
Atara Biotherapeutics, Inc.
Last Price:
$4.99
Seasonality Move:
-0.49%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Atara Biotherapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Atara Biotherapeutics, Inc. has on average historically fallen by 12.4% based on the past 11 years of stock performance.
-
Atara Biotherapeutics, Inc. has fallen lower in 6 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 54.55%
-
Is Atara Biotherapeutics, Inc. Stock Undervalued?The current Atara Biotherapeutics, Inc. [ATRA] share price is $5.00. The Score for ATRA is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
-
ATRA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Atara Biotherapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Atara Biotherapeutics, Inc. has on average historically fallen by 12.4% based on the past 11 years of stock performance.
Atara Biotherapeutics, Inc. Stock Rating
Sell
23
Atara Biotherapeutics, Inc. (ATRA)
is a Sell
Is Atara Biotherapeutics, Inc. overpriced?
-
Atara Biotherapeutics, Inc. has fallen lower in 6 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 54.55%
Atara Biotherapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
atarabio.com
52-Week Data
52-Week High:
19.15
52-Week Low:
4.20
Prediction Charts
Market Cap:
36.1M
Price in USD:
5.00
Volume:
570K
Beta:
0.99
Technical Analysis
SMA50:
13.46
SMA100:
13.55
SMA200:
11.15
52-Wk Change:
-27.43%
Stock Predictions
-
Is Atara Biotherapeutics, Inc. stock public?Yes, Atara Biotherapeutics, Inc. is a publicly traded company.
-
What is the Atara Biotherapeutics, Inc. stock quote today?The Atara Biotherapeutics, Inc. stock price is 5.00 USD today.
-
How to buy Atara Biotherapeutics, Inc. stock online?You can buy Atara Biotherapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-31 | 17.95 | 18.09 | 18.34 | 17.94 |
| Jan-5 | 18.47 | 16.86 | 19.15 | 16.61 |
| Jan-6 | 16.97 | 14.57 | 17.65 | 14.27 |
| Jan-7 | 15.16 | 14.94 | 15.53 | 14.72 |
| Jan-8 | 15.10 | 17.44 | 17.97 | 14.90 |
| Jan-9 | 17.68 | 13.67 | 17.98 | 13.08 |
| Jan-12 | 5.62 | 5.88 | 6.51 | 5.58 |
| Jan-13 | 5.95 | 4.37 | 5.96 | 4.25 |
| Jan-14 | 4.50 | 4.47 | 4.82 | 4.36 |
| Jan-15 | 4.52 | 4.62 | 5.19 | 4.40 |
| Jan-16 | 4.72 | 4.54 | 5.00 | 4.52 |
| Jan-20 | 4.50 | 4.32 | 4.79 | 4.25 |
| Jan-21 | 4.34 | 4.60 | 4.69 | 4.20 |
| Jan-22 | 4.58 | 5.00 | 5.15 | 4.46 |
Atara Biotherapeutics, Inc. Earnings
Atara Biotherapeutics, Inc. Earnings Report: Per Share Atara Biotherapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Atara Biotherapeutics, Inc. Forecast Revenue Growth
Atara Biotherapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Atara Biotherapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.94 per share, and an increase next year of $0.03 per share.
* Atara Biotherapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.